Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can ...

This biotech innovator in inhaled therapeutics reported a notable insider sale amid ongoing product development and licensing ...

He observed that investors are moving into cyclical, real economy stocks, which he finds encouraging because it demonstrates ...

Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings ...

According to TipRanks.com, Renza is a 5-star analyst with an average return of 23.3% and a 49.2% success rate. Renza covers the Healthcare sector, focusing on stocks such as Ascentage Pharma Group ...

According to a filing with the Securities and Exchange Commission dated November 14, Nitorum Capital sold 420,586 shares of Primo Brands Corporation(NYSE:PRMB) during the third quarter. The fund’s ...

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.

The FDA expanded Furoscix use to certain pediatric patients. ・MannKind received five new U.S. patents supporting its ...

FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...

Meta Platforms generates high cash flow and can afford to take risks on AI spending. ASML's lithography machines are essential for manufacturing advanced AI chips. Eli Lilly isn't cheap, but its drug ...

Nutriband shares are trading higher Monday after the company it signed an agreement to sell the majority stake of its ...

Today, investors are waking up to red on their screens as many tech and AI stocks are dropping in premarket trading. But why are shares in these companies falling? Much of it has to do with the cloud ...